The DOI matches its Crossref record; the references it cites are not checked yet.
Salmon calcitonin in the prevention of bone loss at perimenopause
Abstract
The objective of this study was to determine whether intranasal salmon calcitonin prevents physiological bone loss at perimenopause. A double-blind study of 120 perimenopausal women without present or past disease or medication that could affect bone metabolism were studied. The subjects were randomized in two groups and provided with nasal spray bottles containing either placebo (excipient only) or active compound (excipient plus 50 international units (IU) salmon calcitonin per dose). Subjects took one puff from the nasal spray in each nostril every morning. All subjects took one soluble tablet of calcium (1000 mg) per day. Serum biochemistry, dual-energy X-ray absorptiometry of lumbar spine and proximal femur, quantitative computed tomography of lumbar spine, and single photon attenuation of forearm were used to evaluate bone mineral density (BMD). There were no differences in demographic characteristics or hormone status at entry. No fractures were recorded during the study period. Serum calcium increased and serum dihydroxyvitamin D and osteocalcin decreased in both groups. There was no difference in biochemical parameters between the groups. The BMD of upper femur did not change during the study, but it was decreased in the lumbar spine in both groups. The mineral content of distal radius increased in both groups. In conclusion, nasal salmon calcitonin, 100 IU daily, has no protective effect on bone mass and does not modify bone metabolism at perimenopause.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A number of small studies of intranasal or subcutaneous use of sCT showed increases in bone density, reduced number of vertebral fractures, and an association with reduction of the risk of hip fracture (26, 33, 110, 139), whereas others found no bone effects (12).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [12]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 18 · Cited by 40
Metadata
- Authors
- Arnala, I.
- Affiliations
- Kuopio University Hospital (FI)
- Corresponding author
- Arnala, I
- Venue
- Bone
- Publisher
- Elsevier BV
- Published
- 1996-06
- Volume
- 18
- Issue
- 6
- Pages
- 629-632
- ISSN
- 1873-2763 (ISSN-L)
- 8756-3282
- OpenAlex
- W2089089415
- Cited by
- 40
- References
- 18
- Citations by year
- 2025: 1 · 2020: 1 · 2018: 1 · 2013: 1
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Bone (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- salmon calcitonin, intranasal administration, perimenopause, bone loss prevention, bone mineral density, lumbar spine, proximal femur, distal radius, calcium supplementation, osteocalcin, serum calcium, vitamin D, bone metabolism
- MeSH terms
- Administration, Intranasal, Adult, Analgesics, Calcitonin, Dihydroxycholecalciferols, Double-Blind Method, Female, Humans, Lumbar Vertebrae, Middle Aged, Tomography, X-Ray Computed, Biomarkers, Absorptiometry, Photon, Bone Density, Osteoporosis, Postmenopausal, Osteocalcin, Premenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Salmon calcitonin in the prevention of bone loss at perimenopause. https://app.cochat.ai/papers/10.1016/8756-3282(96)00084-1
- The paper
- Arnala, I. (1996). Salmon calcitonin in the prevention of bone loss at perimenopause. Bone. https://doi.org/10.1016/8756-3282(96)00084-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.